Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Gastroesophageal Junction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04281576
What this trial is testing

Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma

Who this might be right for
Gastric CancerGastroEsophageal Cancer
NovoCure Ltd. 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT01512589
What this trial is testing

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center 147
Not applicableStudy completedNCT02305043
What this trial is testing

Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer

Who this might be right for
Esophageal NeoplasmsStomach Neoplasms
University of Leipzig 549
Testing effectiveness (Phase 2)Looking for participantsNCT06469944
What this trial is testing

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Who this might be right for
Gastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Study completedNCT00183872
What this trial is testing

Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerEsophageal Neoplasms
University of Southern California 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07273981
What this trial is testing

Zanidatamab Combined With Chemotherapy as Neoadjuvant Therapy for HER2-high Expression G/GEJC

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
Xijing Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT06764875
What this trial is testing

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

Who this might be right for
HER2-positive Gastric CancerGastroesophageal Junction Adenocarcinoma
AstraZeneca 840
Testing effectiveness (Phase 2)Active Not RecruitingNCT04929392
What this trial is testing

Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer

Who this might be right for
Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8+16 more
City of Hope Medical Center
Not applicableStudy completedNCT03416101
What this trial is testing

Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival

Who this might be right for
Siewert Type II Adenocarcinoma of Esophagogastric Junction
University of Bologna 154
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Not applicableStudy completedNCT02680990
What this trial is testing

Resilience and Exercise in Advanced Cancer Treatment

Who this might be right for
Pancreatic AdenocarcinomaGastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal Junction
Milton S. Hershey Medical Center 14
Early research (Phase 1)Looking for participantsNCT05365581
What this trial is testing

ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 398
Testing effectiveness (Phase 2)Study completedNCT00061932
What this trial is testing

Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+5 more
National Cancer Institute (NCI) 41
Large-scale testing (Phase 3)Study completedNCT02370498
What this trial is testing

Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061)

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Merck Sharp & Dohme LLC 592
Early research (Phase 1)Ended earlyNCT02391038
What this trial is testing

MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C

Who this might be right for
Advanced Gastrointestinal CarcinomaGastroesophageal Junction AdenocarcinomaRecurrent Gastric Adenocarcinoma+4 more
Millennium Pharmaceuticals, Inc. 12
Not applicableNot Yet RecruitingNCT07092449
What this trial is testing

Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma

Who this might be right for
Gastroesophageal JunctionGastric / Gastroesophageal Junction AdenocarcinomaNeoadjuvant Chemoimmunotherapy+1 more
Tang-Du Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04442984
What this trial is testing

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)

Who this might be right for
Gastric Carcinoma Stage IVEsophagogastric Junction Adenocarcinoma Stage IV
Blokhin's Russian Cancer Research Center 326
Testing effectiveness (Phase 2)Study completedNCT00381706
What this trial is testing

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 245
Large-scale testing (Phase 3)Looking for participantsNCT07221149
What this trial is testing

Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Who this might be right for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Bristol-Myers Squibb 690
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938
What this trial is testing

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more
Tao Zhang 70
Next Page
3